A study was just published that analyzed data from over 10,000 other studies in order to make a gigantic meta-analysis that has pretty much shut the door on where we stand with cannabis benefits when it comes to cancer patients. This is 10 times more than the last consensus study that was published in regards to cancer symptoms.
“We expected controversy. What we found was overwhelming scientific consensus,” said the lead author Ryan Castle. “This is one of the clearest, most dramatic validations of medical cannabis in cancer care that the scientific community has ever seen.”
Their study found a 3 to 1 ratio of studies finding that cannabis is effective as a treatment for cancer symptoms. For every study that said it was ineffective, there were 3 saying otherwise. That’s more than enough to be considered a consensus.
“That 3:1 ratio—especially in a field as rigorous as biomedical research—isn’t just unusual, it’s extraordinary.”
At this point, the issue can be put to bed.
“The strong consensus supporting the therapeutic use of cannabis, particularly in the context of cancer, suggests that there is a substantial scientific basis for re-evaluating cannabis’ legal status and its classification as a Schedule I substance.” said the authors.
Read the original article at Marijuana Moment, and the study here.
